InnoCare Pharma Limited (HKG:9969)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
13.30
-0.08 (-0.60%)
Jun 27, 2025, 4:08 PM HKT

InnoCare Pharma Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Operating Revenue
1,2231,008736.99625.41,0431.36
Upgrade
Other Revenue
1.81.81.55---
Upgrade
1,2251,009738.54625.41,0431.36
Upgrade
Revenue Growth (YoY)
71.32%36.68%18.09%-40.04%76368.70%9.38%
Upgrade
Cost of Revenue
150.22138.44128.44143.465.67-
Upgrade
Gross Profit
1,075871.01610.1482.01977.371.36
Upgrade
Selling, General & Admin
613.32588.49551.01613.27436.89157.58
Upgrade
Research & Development
844.48814.61757.25639.14721.58402.77
Upgrade
Other Operating Expenses
18.4811.13-26.7671.42-
Upgrade
Operating Expenses
1,4781,4161,2821,2591,160560.35
Upgrade
Operating Income
-402.87-544.71-671.67-777.4-182.53-558.99
Upgrade
Interest Expense
-42.14-33.79-35.21-17.05-2.64-1.14
Upgrade
Interest & Investment Income
175.79178.71197.9145.4135.2198.58
Upgrade
Earnings From Equity Investments
1.42---9.71-0.6-
Upgrade
Currency Exchange Gain (Loss)
-43.65-43.65-87.84-57.14108.29
Upgrade
Other Non Operating Income (Expenses)
10.84-0.386.57-244.9317.5930.58
Upgrade
EBT Excluding Unusual Items
-300.6-443.83-590.24-903.6824.16-322.68
Upgrade
Gain (Loss) on Sale of Investments
-11.42-30.46-53.966.566.73-
Upgrade
Asset Writedown
-0.29-0.1----
Upgrade
Other Unusual Items
21.7821.81-3.4-51.01-69.18
Upgrade
Pretax Income
-290.54-452.59-644.21-893.73-20.12-391.87
Upgrade
Income Tax Expense
2.180.261.43-46.56-
Upgrade
Earnings From Continuing Operations
-292.72-452.86-645.63-893.73-66.68-391.87
Upgrade
Minority Interest in Earnings
12.4612.2214.377.132.130.47
Upgrade
Net Income
-280.26-440.63-631.26-886.59-64.55-391.4
Upgrade
Net Income to Common
-280.26-440.63-631.26-886.59-64.55-391.4
Upgrade
Shares Outstanding (Basic)
1,6991,6951,7061,4801,366968
Upgrade
Shares Outstanding (Diluted)
1,6991,6951,7061,4801,366968
Upgrade
Shares Change (YoY)
-7.72%-0.67%15.31%8.29%41.21%321.19%
Upgrade
EPS (Basic)
-0.16-0.26-0.37-0.60-0.05-0.40
Upgrade
EPS (Diluted)
-0.16-0.26-0.37-0.60-0.05-0.40
Upgrade
Free Cash Flow
-292.26-443.78-920.14-792.79-2.71-423.51
Upgrade
Free Cash Flow Per Share
-0.17-0.26-0.54-0.54-0.00-0.44
Upgrade
Gross Margin
87.74%86.28%82.61%77.07%93.70%100.00%
Upgrade
Operating Margin
-32.89%-53.96%-90.95%-124.30%-17.50%-40981.38%
Upgrade
Profit Margin
-22.88%-43.65%-85.47%-141.76%-6.19%-28694.65%
Upgrade
Free Cash Flow Margin
-23.86%-43.96%-124.59%-126.76%-0.26%-31049.41%
Upgrade
EBITDA
-334.06-477.69-611.8-731.46-167.2-556.92
Upgrade
EBITDA Margin
-27.27%-47.32%-82.84%-116.96%-16.03%-
Upgrade
D&A For EBITDA
68.8167.0259.8745.9415.332.07
Upgrade
EBIT
-402.87-544.71-671.67-777.4-182.53-558.99
Upgrade
EBIT Margin
-32.89%-53.96%-90.95%-124.30%-17.50%-
Upgrade
Revenue as Reported
1,2251,009738.54---
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.